Reuters logo
BRIEF-Zhejiang Hisun Pharmaceutical gets nod for clinic trial
May 26, 2016 / 6:16 AM / a year ago

BRIEF-Zhejiang Hisun Pharmaceutical gets nod for clinic trial

May 26 (Reuters) - Zhejiang Hisun Pharmaceutical Co., Ltd. :

* Says it gets China Food and Drug Administration’s approval for its ticagrelor and other medicines and injections’ clinic trial

Source text in Chinese: goo.gl/xSqKBK

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below